• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

11例因新型冠状病毒肺炎死亡患者肺部尸检的组织病理学检查:病例系列

Histopathological Examination of Lung Necropsy of 11 Patients Who Died Due to COVID-19: A Case Series.

作者信息

Nikkhoo Bahram, Naseri Karim, Rahimi Darehbagh Ramyar, Habiby Mehrdad, Moasses-Ghafari Bahar

机构信息

Department of Pathology, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Department of Anesthesiology, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

出版信息

Iran J Pathol. 2024 Winter;19(1):126-131. doi: 10.30699/IJP.2023.2008773.3153. Epub 2023 Dec 29.

DOI:10.30699/IJP.2023.2008773.3153
PMID:38864091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11164306/
Abstract

COVID-19 is known to present with acute respiratory distress syndrome pathological manifestations. Studies have shown that patients with COVID-19 can develop diffuse alveolar damage, acute bronchopneumonia, necrotic bronchiolitis, and viral pneumonia. In this study, we investigated 11 cases. Needle necropsies of 11 patients, hospitalized at Tohid and Kowsar hospitals of Kurdistan University of Medical Sciences, with a positive antemortem SARS-CoV-2 (COVID-19) real-time PCR test, were fixated within 3 hours after death in the negative-pressure isolation morgue. The participants included six men (54%) and five women (46%) with a mean age of 73.82±10.58 (52-86) years old. The average hospitalization was 14.27±15.72 days. The results showed interstitial lymphocytic pneumonitis in most of the cases, varied from mild to moderate and up to severe in some cases. In 7 cases, anthracosis was noted, while one case demonstrated anthracosis with fibrosis. The hyaline membrane was reported in two patients. In one case, severe interstitial lymphocytic pneumonia with intra-alveolar exudate with organization, lithiasis, bronchiolitis pattern (BOOP), intra-alveolar hemorrhage, and mild fibrosis were seen. As a result, it is suggested to keep an eye on these pathologies in management of the severe cases of COVID-19 infection.

摘要

已知新冠病毒病会出现急性呼吸窘迫综合征的病理表现。研究表明,新冠病毒病患者可出现弥漫性肺泡损伤、急性支气管肺炎、坏死性细支气管炎和病毒性肺炎。在本研究中,我们调查了11例病例。对库尔德斯坦医科大学托希德医院和科萨尔医院收治的11例生前严重急性呼吸综合征冠状病毒2(新冠病毒病)实时聚合酶链反应检测呈阳性的患者进行了针吸尸检,在负压隔离停尸房于死亡后3小时内进行固定。参与者包括6名男性(54%)和5名女性(46%),平均年龄为73.82±10.58(52 - 86)岁。平均住院时间为14.27±15.72天。结果显示,大多数病例为间质性淋巴细胞性肺炎,程度从轻度到中度不等,部分病例可达重度。7例发现炭末沉着症,1例显示炭末沉着症伴纤维化。2例患者出现透明膜。1例患者可见严重的间质性淋巴细胞性肺炎伴肺泡内渗出物机化、结石形成、细支气管炎样改变(闭塞性细支气管炎伴机化性肺炎)、肺泡内出血和轻度纤维化。因此,建议在新冠病毒病感染重症病例的管理中关注这些病理情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3157/11164306/10729c12a3eb/ijp-19-126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3157/11164306/83b64d7667f2/ijp-19-126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3157/11164306/34374c4bb06e/ijp-19-126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3157/11164306/10729c12a3eb/ijp-19-126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3157/11164306/83b64d7667f2/ijp-19-126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3157/11164306/34374c4bb06e/ijp-19-126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3157/11164306/10729c12a3eb/ijp-19-126-g003.jpg

相似文献

1
Histopathological Examination of Lung Necropsy of 11 Patients Who Died Due to COVID-19: A Case Series.11例因新型冠状病毒肺炎死亡患者肺部尸检的组织病理学检查:病例系列
Iran J Pathol. 2024 Winter;19(1):126-131. doi: 10.30699/IJP.2023.2008773.3153. Epub 2023 Dec 29.
2
Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome.T细胞在与呼肠孤病毒1/L诱导的闭塞性细支气管炎伴机化性肺炎和急性呼吸窘迫综合征相关的纤维化病变发展中的不同作用。
Am J Respir Cell Mol Biol. 2003 Feb;28(2):208-17. doi: 10.1165/rcmb.4891.
3
[Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].[2019年新型冠状病毒肺炎(COVID-19)致死病例肺部病理改变:经皮针吸尸检10例报告]
Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):568-575. doi: 10.3760/cma.j.cn112151-20200405-00291.
4
Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.细支气管炎性间质性肺炎:31例肺活检的病理学研究,其特征介于闭塞性细支气管炎并机化性肺炎和普通间质性肺炎之间,并与临床相关。
Ann Diagn Pathol. 2008 Jun;12(3):171-80. doi: 10.1016/j.anndiagpath.2007.07.002. Epub 2007 Oct 24.
5
The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities.新型冠状病毒病 2019(COVID-19)的心肺病理学:来自德克萨斯州休斯顿的 3 例尸检报告,并回顾了美国其他城市的尸检结果。
Cardiovasc Pathol. 2020 Sep-Oct;48:107233. doi: 10.1016/j.carpath.2020.107233. Epub 2020 May 7.
6
Histopathological changes in lungs of patients with fatal COVID 19 infection: A series of 15 cases.新型冠状病毒肺炎致死病例肺部的组织病理学变化:15例病例系列研究
Indian J Pathol Microbiol. 2023 Oct-Dec;66(4):834-838. doi: 10.4103/ijpm.ijpm_866_21.
7
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
8
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果:一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
9
Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.雾化吸入重组人脱氧核糖核酸酶治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征患者的疗效和安全性:一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Jun 19;21(1):548. doi: 10.1186/s13063-020-04488-8.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

本文引用的文献

1
Histopathologic survey on lung necropsy specimens of 15 patients who died from COVID-19: A large study from Iran with a high rate of anthracosis.对15例死于新型冠状病毒肺炎患者的肺尸检标本进行组织病理学调查:来自伊朗的一项大规模研究,煤尘肺发病率高。
Med J Islam Repub Iran. 2021 May 17;35:63. doi: 10.47176/mjiri.35.63. eCollection 2021.
2
Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy.
Lung India. 2021 Jul-Aug;38(4):343-349. doi: 10.4103/lungindia.lungindia_919_20.
3
Postmortem lung biopsies from four patients with COVID-19 at a tertiary hospital in Cape Town, South Africa.南非开普敦一家三级医院的 4 名 COVID-19 患者的死后肺活检。
S Afr Med J. 2020 Oct 19;110(12):1195-1200. doi: 10.7196/SAMJ.2020.v110i12.15290.
4
What Open-Lung Biopsy Teaches Us about ARDS in COVID-19 Patients: Mechanisms, Pathology, and Therapeutic Implications.COVID-19 相关急性呼吸窘迫综合征的开肺活检研究进展:机制、病理及治疗意义。
Biomed Res Int. 2020 Dec 9;2020:2909673. doi: 10.1155/2020/2909673. eCollection 2020.
5
Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.新型冠状病毒病 2019 与严重急性呼吸综合征和 H1N1 流感的肺部组织病理学比较:系统综述。
Chest. 2021 Jan;159(1):73-84. doi: 10.1016/j.chest.2020.09.259. Epub 2020 Oct 7.
6
SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?'.严重急性呼吸综合征冠状病毒 2 型所致机化性肺炎:“在 COVID-19 中,是否广泛存在未能识别和治疗这种普遍存在的疾病的情况?”。
BMJ Open Respir Res. 2020 Sep;7(1). doi: 10.1136/bmjresp-2020-000724.
7
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.COVID-19 肺部病理学:来自意大利和纽约市的多机构尸检队列研究。
Mod Pathol. 2020 Nov;33(11):2156-2168. doi: 10.1038/s41379-020-00661-1. Epub 2020 Sep 2.
8
The Spectrum of Histopathologic Findings in Lungs of Patients With Fatal Coronavirus Disease 2019 (COVID-19) Infection.COVID-19 患者肺部组织病理学表现。
Arch Pathol Lab Med. 2021 Jan 1;145(1):11-21. doi: 10.5858/arpa.2020-0491-SA.
9
A review of the main histopathological findings in coronavirus disease 2019.2019年冠状病毒病主要组织病理学发现综述
Hum Pathol. 2020 Nov;105:74-83. doi: 10.1016/j.humpath.2020.07.023. Epub 2020 Aug 2.
10
Symptoms of Pleurisy as the Initial Presentation of COVID-19.胸膜炎作为新冠病毒病的首发症状
Am J Case Rep. 2020 Jul 24;21:e925775. doi: 10.12659/AJCR.925775.